LJI Scientists Uncover the Structure and Function of Inmazeb, the first FDA-Approved Drug for Ebola Virus Infection

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.lji.org/news-events/news/post/lji-scientists-uncover-the-structure-and-function-of-inmazeb-the-first-fda-approved-drug-for-ebola-virus-infection/
Research Institution
La Jolla Institute for Immunology
Short Title
LJI Scientists Uncover the Structure and Function of Inmazeb, the first FDA-Approved Drug for Ebola Virus Infection
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald